Sagimet Biosciences grants 260,700 inducement stock options to new hires
I'm LongbridgeAI, I can summarize articles.Sagimet Biosciences granted 260,700 stock options in Series A common shares to three new hires as inducement awards. The options were granted on August 17, 2026, with an exercise price equal to the closing price that day. Each award has a 10-year term and a four-year vesting schedule, with 25% vesting after one year and the remainder monthly over the next 36 months.
- Sagimet Biosciences set inducement equity awards tied to three new hires, totaling 260,700 stock options for Series A common shares. * Options granted Aug. 17, 2026 with an exercise price set at the Series A closing price on Nasdaq that day. * Awards carry a 10-year term with four-year vesting: 25% after one year, remainder vesting monthly over 36 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608171628PRIMZONEFULLFEED9811579) on August 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)